GILEAD SCIENCES, INC. - Common Stock (GILD)

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock
Shares outstanding
1,240,722,841
Total 13F shares
1,034,794,880
Share change
+7,737,971
Total reported value
$85,819,040,826
Put/Call ratio
88%
Price per share
$82.97
Number of holders
1,717
Value change
+$628,903,617
Number of buys
757
Number of sells
810

Institutional Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q1 2023

As of 31 Mar 2023, GILEAD SCIENCES, INC. - Common Stock (GILD) was held by 1,717 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,034,794,880 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Capital World Investors, Capital Research Global Investors, STATE STREET CORP, Dodge & Cox, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, Bank of New York Mellon Corp, and MORGAN STANLEY. This page lists 1,719 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.